EMA: On­go­ing study da­ta of Cell­tri­on’s mAb enough to al­low its use in some Covid-19 pa­tients

The Eu­ro­pean Med­i­cines Agency added an­oth­er mon­o­clon­al an­ti­body to the con­ti­nent’s Covid-19 ther­a­peu­tics ar­se­nal on Fri­day, con­clud­ing that Cell­tri­on’s reg­dan­vimab can be used as a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER